FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/02/030946 [Registered on: 02/02/2021] Trial Registered Prospectively
Last Modified On: 01/02/2021
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Correlation of Vitamin B12 with blood clotting in COVID-19 patients 
Scientific Title of Study   A study of correlation between Vitamin B12 levels and D-dimer levels - in COVID-19 positive patients at our hospital 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Karmay H Shah 
Designation  Post Graduate Student 
Affiliation  GCS Medical College, Hospital and Research Centre 
Address  OPD 28, GCS Medical College, Hospital and Research Centre, Opposite DRM Office, Naroda Road, Ahmedabad
Room 303, G2 block, GCS HOSTEL,Opp DRM Office, Naroda Road, Ahmedabad
Ahmadabad
GUJARAT
380025
India 
Phone  07966048028  
Fax    
Email  karmay.shah@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rushi Patel 
Designation  Associate Professor 
Affiliation  GCS Medical College, Hospital and Research Centre 
Address  OPD 28, GCS Medical College, Hospital and Research Centre, Opposite DRM Office, Naroda Road, Ahmedabad
GCS Medical College, Hospital and Research Centre, Opposite DRM Office, Naroda Road, Ahmedabad
Ahmadabad
GUJARAT
380025
India 
Phone  07966048028  
Fax    
Email  Rrpatel9@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Karmay H Shah 
Designation  Post Graduate Student 
Affiliation  GCS Medical College, Hospital and Research Centre 
Address  OPD 28, GCS Medical College, Hospital and Research Centre, Opposite DRM Office, Naroda Road, Ahmedabad

Ahmadabad
GUJARAT
380025
India 
Phone  07966048028  
Fax    
Email  karmay.shah@yahoo.co.in  
 
Source of Monetary or Material Support  
GCS Medical College Hospital and Research Centre, Opp DRM office, Naroda road, Ahmedabad 
 
Primary Sponsor  
Name  GCS Medical College Hospital and Research Centre 
Address  GCS Medical College, Hospital and Research Centre, Opposite DRM Office, Naroda Road, Ahmedabad 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Karmay Shah  GCS Medical College, Hospital and Research Centre  OPD room number 28, Opposite DRM Office, Beside Chamunda bridge, Naroda Road
Ahmadabad
GUJARAT 
07966048028

karmay.shah@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, GCS Medical College, Hospital and Research Centre  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B972||Coronavirus as the cause of diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  nil  nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1.All patients who are COVID-19 positive by either COVID-19 RTPCR test or COVID-19 rapid antigen test or HRCT chest suggestive of active COVID-19 infection (CORADS III AND ABOVE)
2.All genders
3.Age above 18 years
4.Patients willing to give consent for this study
 
 
ExclusionCriteria 
Details  1.Patients who are COVID-19 negative
2.Patients who have taken Vitamin B12 supplements
3.Patients who might have raised D-Dimer due to other known causes; e.g. heart disease, prolonged bed rest, post surgical, etc
4.Pregnant and lactating women
5.Age <18 years
6.Patients not willing to give consent for this study
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To measure baseline Vitamin B12 levels in COVID19 positive patients
2.To measure baseline D Dimer levels in these patients
3.To measure maximum D Dimer levels in these patients through the course of hospital stay
4.To analyse following in the study population:

Duration of hospital stay
Need for oxygen support
Need for anticoagulation
Clinical outcome(recovered/expired)
 
2 months 
 
Secondary Outcome  
Outcome  TimePoints 
To compare thrombotic events in persons with Vitamin B12 deficiency and in those with normal levels  2 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   17/02/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Aims-

To compare Vitamin B12 levels and D-dimer levels of COVID 19 positive patients

To establish, if any, correlation between Vitamin B12 deficiency and increased thrombosis (by means of D-Dimer) in the study population

 
Close